STERIS plc
STERIS plc (STE) — Form 8-K: Current report
AI-generated summary
STERIS plc entered into a new $1,600 million revolving credit agreement, replacing its existing agreement dated October 7, 2024. The company also secured a $500 million delayed draw term loan agreement to support the Xodus Medical Acquisition. Both agreements were established on November 4, 2026.
Key facts
- Item 1.01 · Entry into a material agreement
- Item 1.02 · Termination of a material agreement
- Item 2.03 · New debt or another financial obligation
- Item 9.01 · Financial statements and exhibits
More STE filings
- 8-K
Filed Nov 4, 2026
- 8-K
Filed Oct 13, 2026
- 4
Filed Oct 5, 2026
- 144
Filed Aug 18, 2026
- 4
Filed Aug 12, 2026
- 4
Filed Aug 12, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.